1.Stahl SM. The Prescriber's Guide: Stahl's Essential Psychopharmacology, 4th ed. New York: Cambridge University Press; 2011.
2.Devulapalli K, Nasrallah HA. An analysis of the high psychotropic off-label use in psychiatric disorders: the majority of psychiatric diagnoses have no approved drug. Asian J Psychiatr. 2009; 2: 29–36.
3.Baldwin DS, Kosky N. Off label prescribing in psychiatric practice. Advances in Psychiatric Treatment. 2007; 13: 414–422.
4.Silberstein SD, Marmura MJ, Stahl SM, eds. Essential Neuropharmacology: The Prescriber's Guide. Cambridge, UK: Cambridge University Press; 2010.
5.Pappagallo M, Smith H, Stahl SM. Essential Pain Pharmacology: The Prescribers Guide. Cambridge, UK: Cambridge University Press; 2012.
6.Radley DC, Finkelstein SN, Stafford RS. Off label prescribing among office-based physicians. Arch Intern Med. 2006; 166: 1021–1026.
7.Willick D. A cautionary tale about off label prescribing. California Psychiatrist: The Newsletter of the California Psychiatric Association. 2012; 27(1): 3–4.
8.Ali SI, Ajmal SR. When is off-label prescribing appropriate? Current Psychiatry. 2012; 11: 23–27.
9.Gazarian M, Keely M, McPhee JR. Off label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006; 185: 544–548.
10.Kramer SL, McCall WV. Off label prescribing: 7 steps for safer, more effective prescribing. Current Psychiatry. 2006; 5: 14–28.
11.Stahl SM. The tyranny of the majority and the interchangeability of drugs. Acta Psychiatrica Scand. 2013; 127: 4–5.
12.Isaacs D, Fitzgerald D. Seven alternatives to evidence based medicine. BMJ. 1999; 319: 7225.
13.Stahl SM. Case Studies: Stahl's Essential Psychopharmacology. New York: Cambridge University Press; 2011.